Oxidative damage can lead to a number of diseases, and can be fatal. The blm1-1 mutation of Saccharomyces cerevisiae confers hypersusceptibility to lethal effects of the oxidative, anticancer and antifungal agent, bleomycin. For the current report, additional defects conferred by the mutation in meiosis and mitosis were investigated. The viability of spores produced during meiosis by homozygous normal BLM1/BLM1, heterozygous BLM1/blm1-1, and homozygous mutant blm1-1/blm1-1 diploid strains was studied and compared. Approximately 88% of the tetrads derived from homozygous blm1-1/blm1-1 mutant diploid cells only produced one or two viable spores. In contrast, just one tetrad among all BLM1/BLM1 and BLM1/blm1-1 tetrads only produced one or two viable spores. Rather, 94% of BLM1/BLM1 tetrads and 100% of BLM1/blm1-1 tetrads produced asci with four or three viable spores. Thus, at least one copy of the BLM1 gene is essential for the production of four viable spores after meiosis. During mitotic growth, mutant blm1-1 strains grew at reduced rates and produced cells with high frequencies of unusual morphologies compared to wild-type strains. These results indicated BLM1 is also essential for normal mitotic growth. We also investigated the suppression by the MSH4 gene, a meiosis-specific MutS homolog, of the bleomycin hypersusceptibility of blm1-1 mutant cells, and the relationship of MSH4 to BLM1. We screened a genomic library, and isolated the MSH4 gene on the basis of its ability to suppress lethal effects of bleomycin in blm1-1 cells. However, genetic mapping studies indicated that BLM1 and MSH4 are not the same gene. The possibility that chromosomal nondisjunction could be the basis for the inability of blm1-1/ blm1-1 mutant cells to produce four viable spores after meiosis is discussed.
Introduction
The structures of bleomycins and structurally-related phleomycin are shown in Figure 1 . These low molecular weight compounds cause single-and double-stranded breaks in DNA [1] and damage to fungal cell walls [2] . They bind to DNA and generate free radicals in an oxygen-dependent, metaldependent reaction [3] [4] [5] . Bleomycins and phleomycins are radiomimetic in that they produce effects similar to those observed after exposure of DNA to ionizing radiation [6] [7] [8] [9] . As a result, the drugs are employed as tools in studies of oxidative damage to cells [10] . To gain knowledge about how cells respond to oxidative damage, we isolated a series of mutants in Saccharomyces cerevisiae that confer hypersensitivity to killing by the bleomycins and phleomycins. One of these mutants contained the recessive blm1-1 mutation [11, 12] .
Additional defects conferred by blm1-1 were investigated for the current report. We also describe the cloning and isolation of the MSH4 gene, essential for wild-type spore viability in S. cerevisiae [13] .
The Msh4 protein is a homolog of the MutS DNA mismatch repair protein in bacteria [14] . Tetrad analyses indicated that the BLM1 gene is essential for the production of four viable spores after meiosis, and mitotic analyses indicated BLM1 is essential for normal mitotic growth. 
Materials and Methods

Strains and Plasmids
The yeast and bacterial strains used in this work are listed in Table 1 . 
Media and Growth Conditions
Non-synthetic complete solid medium (YPAD), containing 2% glucose, 2% Bacto-peptone, (Difco Laboratories, Detroit, Michigan), 1% Bacto-yeast extract (Difco), 2% Bacto-agar (Difco), and 0.16 mg/ml adenine sulfate were used for the nonselective growth of all yeast strains. If liquid YPAD medium was required, agar was not included in the preparation. Solid synthetic medium (SD) was used for the selective growth of desired strains. It contained 0.2% Bacto-yeast nitrogen base (Difco), 0.5% ammonium sulfate, 2% glucose, and 2.5% Bacto-agar. For strain selection or for the growth of individual strains during screening procedures, the specific amino acid requirements of each strain were added during the preparation of SD medium.
Sporulation and Dissection of Tetrads
The steps involved in mating of haploid strains to produce diploid cells, sporulation of diploids, and analysis of tetrads after meiosis are outlined in Figure 2 . The yeast haploids of opposite mating types were crossed, and the resulting diploids were selected on supplemented SD media. A colony from the selected diploids was inoculated into sterile liquid YPAD medium and incubated with aeration at 30 o C overnight. Cells were grown to stationary phase, then inoculated at a cell density of 1000 cells/ml into presporulation media containing 0.8% Bacto-yeast extract (Difco), 0.3% Bacto-peptone (Difco), 10% 
Zeocin Treatments
Zeocin is a 20-fold dilution of phleomycin, and was purchased from Invitrogen (Carlsbad, CA).
Aliquots from the stock solution of Zeocin were added to the desired concentration in SD or YPAD media which had been sterilized and cooled to approximately 45 o C. Zeocin medium was always prepared within 24 hours prior to use. Yeast strains listed in Table 1 were replica-plated on Zeocin media and grown for 3 days at 30 o C to determine their susceptibility to killing by the drug.
E. coli and Yeast Transformations
E. coli transformation was carried out according the CaCl 2 method described by Sambrook et al. [17] . Transformation of yeast cells was carried out using lithium acetate in the method of Ito and co-workers [18] and as modified by Rose [19] and Rose and Broach [20] .
Results
Reduced Viability of Spores from Homozygous Mutant Strains
The viability of spores from homozygous blm1-1/blm1-1 mutant strains was compared to that of spores from BLM1/BLM1 homozygous normal strains and heterozygous BLM1/blm1-1 strains. The homozygous normal diploid was created by crossing two wild-type haploid segregants, CM1457-79A
and CM1457-79B (Table 1 ). The heterozygous diploid was created by crossing a wild-type haploid, CM1457-79A, to a mutant haploid, CM1457-79C. The homozygous mutant diploid was created by crossing two mutant haploids, CM1457-79C and CM1457-79D. Each diploid was sporulated, and the tetrads obtained from each sporulated diploid were dissected ( Figure 2 ).
The viability of the spores in each tetrad is tabulated in Table 2 . Ninety-four percent of the tetrads from the BLM1/BLM1 diploid and 100% of the tetrads from the BLM1/blm1-1 diploids produced four or three viable spores. In contrast, no tetrads from blm1-1/blm1-1 cells produced asci with four viable spores, and only 13% of the tetrads produced three viable spores. One-or two-spored viability was predominant. Thus, in the presence of one or two copies of the BLM1 gene (as in homozygous or heterozygous diploids), tetrads appear capable of completing meiosis and producing four viable spores.
However, in the absence of the BLM1 gene, cells appear unable to complete meiosis and produce four viable spores. These results indicate that the BLM1 gene is essential for the viability of all four spores after meiosis, and that the blm1-1 mutation confers a deficiency in meiosis since the homozygous mutant cells are unable to produce four viable spores. 
Mitotic Phenotype of blm1-1 Mutant Strains: Reduced Growth Rate and Elevated Frequencies of
Irregularly-shaped Cells
Mutant blm1-1 strains were found to grow at reduced rates compared to the wild-type strains. At stationary phase, the titers of blm1-1 haploid strains were approximately 25% less than those of BLM1 cells (Table 3) . During growth, the blm1-1 mutant cells also assumed peculiar shapes at high frequencies. When quantitated, approximately five percent of blm1-1 cells in stationary-phase populations were abnormally shaped. In addition, twice as many cells appeared swollen in blm1-1 populations than in BLM1 populations. 1 Each cell was classified based on the following criteria and relative sizes.
2 Irregularly-shaped cells: . 3 Normal-sized single cells and budded cells: . 4 Enlarged cells: .
Isolation of Plasmids, Restriction Analyses, and DNA Sequence Analyses
In addition to the meiotic defect, the blm1-1 mutation confers hypersensitivity to lethal effects of bleomycin [21] . Thus, this phenotype was used to isolate plasmids that relieved the drug hypersensitivity. Isolation of the pPM118 and pPM118-4 plasmids from a S. cerevisiae (S288C) genomic library was previously described [22] . A 32 P-labelled 3.8 kb BamHI-ClaI fragment from pPM118 was used as a probe to screen the genomic library and isolate pPM118-4.
To identify the complete sequences of the inserts in pPM118 and pPM118-4, approximately 200
bases at each end of the inserts were sequenced by two custom-made primers originating from the vector sequences. These four end sequences were then used to search the nucleotide sequence databases through the National Center for Biological Information (NCBI) using the BLAST program [23] . These sequences were also used to search the SGD (Saccharomyces Genomic Database). The 
Relief of Drug Hypersensitivity
The relief of the hypersensitivity to killing by bleomycin conferred by the pPM118-4 plasmid is illustrated in Figure 4 Second, whether MSH4 and BLM1 are or are not the same gene, the full gene may be required on the plasmid to obtain full complementation. Third, the encoded protein may not be produced as efficiently from the plasmid as it is from the chromosome. Fourth, the region of the gene on pPM118 may contain an alteration.
Genetic Mapping Showed that MSH4 is not the BLM1 Structural Gene
The MHS4 gene has one function that is similar to that of the BLM1 gene -both genes are required in meiosis for wild-type levels of spore viability in S. cerevisiae. Thus, to determine if BLM1and MSH4 are the same gene, linkage analysis was carried out by genetic mapping to determine if MSH4 is linked to (and thus could be) the BLM1 gene.
A mutant strain, PS593/6H, with the LEU2 marker replacing nucleotides 168-2290 of the MSH4 coding region [15] , was kindly provided by Dr. Nancy Hollingsworth (Department of Biochemistry and Cell Biology, State University of New York at Stony Brook, Stony Brook, NY). This strain was crossed to a leu2/blm1-1 strain, CM1457-79C. The resulting diploid was genotypically MSH4/msh4::LEU2, BLM1/blm1-1. The LEU2 gene was used to track the msh4 gene in linkage analysis, and Zeocin hypersensitivity was used to track the blm1-1 mutation. If the two genes are the same, the genotypes in the tetrad segregants would be one or the other of the parental ditypes (PD).
That is, there will be 2:2 segregation of LEU2 (leucine prototrophy) with BLM1 (wild-type or normal drug resistance), and leu2 (leucine auxotrophy) with the blm1-1 mutation (drug hypersensitivity).
Segregation of BLM1, blm1-1, MSH4 and msh4::LEU2 in meiosis is shown in Table 4 . The segregation pattern from the tetrad analysis of the cross PS593/6H x CM1457-79C revealed that 35.7%
of the tetrads were PD, 42.9% of the tetrads were non-parental ditypes (NPD; the genotypes of all four spores are different from the genotypes of the parental haploids), and 21.4% were tetratypes (TT; two spores are parental genotypes and two spores are not). For two genes to be linked, the ratio of PD:
NPD: TT is >1: <1:0 [24] . The ratio obtained from this assay is <1:1<1. Actually, the ratio of each genotype among the total spores is close to 1:1:1:1, consistent with random assortment of each gene on its respective chromosome. Thus, the linkage analysis indicates that MSH4 and BLM1 are different genes.
A master plate containing solid YPAD medium and inoculated with parental strains, all the spores from dissected tetrads, and positive controls were created. Cells from this plate were replica-plated on SD+7 media lacking leucine and on complete media containing Zeocin. The MSH4 gene was tracked by the wild-type LEU+ phenotype from PS593/6H, and the BLM1 phenotype was introduced into the cross by PS593/6H. (Table 2 ). But the fact that only one or two spores from 88% of the tetrads survived indicates some step in meiosis is likely to be defective. One possibility for the defect is that nondisjunction of one or more chromosomes occurs at high frequency during meiosis in the mutant diploids. A failure of chromosomes to properly separate could occur at either the first or second meiotic division, as shown in Figure 5 . Disturbance of the structural components of the synaptonemal complex in meiosis can lead to nondisjunction of homologous chromosomes [25] . Although the relationship between the Blm1p and nondisjunction is unknown, it is known that Msh4p functions in the formation of the synaptonemal complex [15] . The MSH4 gene in S. cerevisiae encodes a protein involved in crossing over between chromosomes in meiosis, and the gene is not transcribed in mitosis [25] . Recently, Msh4p was shown to function in chromosomal synapsis in meiosis, and regulate the distribution of meiotic crossovers along chromosomes [15] . The protein localizes to discrete sites in meiotic chromosomes when synapsis initiates, and promotes formation of the synaptonemal complex [15] .
